|

Where
possible, links are to the specific issue of the journal in which the
article(s) appears.
February 2003
- Neurology,
Feb. 25/03
- Does compensatory
hyperparathyroidism predispose to ischemic stroke?
- The effect of pneumonia on
mortality among patients hospitalized for acute stroke
- N
Engl J Med, Feb. 20/03
- Readability Standards for
Informed-Consent Forms as Compared with Actual Readability
- N
Engl J. Med - Feb. 13/03
- Clinical Practice - Initial
Treatment of Hypertension - Phyllis August
- Neurology,
Feb. 11/03
- Asymptomatic microbleeds as a
risk factor for aspirin-associated intracerebral hemorrhages
- Stroke;
Volume 34, Number 2, February 2003
- Estrogen and Stroke - P.
Hurn, L. Brass
- Stroke Genetics Update - M.
Alberts
- Stroke Neuroimaging - S.
Warrach
- Statins in Threatened Stroke -
M. Kaste
- Angiotensin-converting enzyme
inhibitors for Stroke Prevent Is there HOPE for PROGRESS after
LIFE? - G. Hankey
- Emerging Therapies for Acute
Ischemic Stroke New Therapies on Trial - M. Fisher, T. Brott
- Review of Critical Care and
Emergency Approaches to Stroke - D. Hanley
- Are some patients likely to
benefit from Recombinant Tissue-type Plasminogen activator for
acute ischemic stroke even beyond 3 hours from symptom onset?
- D. Kent, R. Ruthazer, H. Selker
- Stroke;
Volume 34, Number 2, February 2003
- Tolerability of NXY-059 at
Higher Target Concentrations in Patients with Acute Stroke
- Stroke;
Volume 34, Number 2, February 2003
- Vampire Bat Salivary
Plasminogen Activator (Desmoteplase) A unique fibrinolytic
enzyme that does not promote neurodegeneration
|